The report shows that CDNetworks' security platform intercepted 887.4 billion web attacks targeting applications and APIs in ...

Fintel reports that on May 28, 2025, Leerink Partners downgraded their outlook for Rocket Pharmaceuticals (NasdaqGM:RCKT) ...

T therapies is an expensive business. The fundamental problem is that CAR-T production is not a good fit for centralized manufacturing.

FDA places clinical hold of RP-A501 for the treatment of patients with Danon disease due to a patient death. Click here to ...

Sami Corwin, an analyst at William Blair, maintained his Outperform rating on Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) on ...

Wacker and Expression Manufacturing want to offer clients with an end-to-end, optimized solution for viral vector development and production.

TransCode Therapeutics, Inc. , a clinical-stage oncology company developing RNA-targeted therapeutics for the treatment of cancer, today announced the appointment of Phillip D. Zamore, Ph.D., to its ...

Fintel reports that on May 28, 2025, Jefferies downgraded their outlook for Rocket Pharmaceuticals (NasdaqGM:RCKT) from Buy ...

US biotech Lexeo Therapeutics has secured $80 million from a private placement, giving the company enough capital to push ...

Dengue Vaccines Market Projected to Grow from USD 90 Million in 2025 to Nearly USD 200 Million by 2035The global Dengue Vaccines Market is expected to be reach USD 90.0 million in 2025 and is likely ...